We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.90
Bid: 16.80
Ask: 18.50
Change: 1.15 (6.97%)
Spread: 1.70 (10.119%)
Open: 16.90
High: 16.90
Low: 16.90
Prev. Close: 16.50
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Update and NAV Estimate as at 31 Dec 2019

30 Jan 2020 10:21

RNS Number : 4394B
LMS Capital PLC
30 January 2020
 

30 January 2020

 

 

LMS Capital plc

Company Update and NAV Estimate as at 31 December 2019

 

LMS Capital plc (the "Company") the listed Investment Company provides the following Company update and estimate of net asset value as at 31 December 2019.

 

Company update

 

The new Board appointed on 28 November 2019 is pleased to report that in the two months since the shareholder meeting the Company has commenced making the necessary changes to transition to internal management.

- As reported in its announcement on 29 November 2019, the Company submitted a request to the FCA for registration as an AIFM, which is necessary for internal management. The Company was notified on 20 December 2019 that the FCA is minded to approve the application for registration as an AIFM, subject to the Company agreeing early termination of the Gresham House Asset Management Limited ("GHAM") contract;

- On 29 January 2020, the Company agreed with GHAM to terminate the GHAM contract with immediate effect upon the entry of the Company on the register of small registered UK AIFMs maintained by the FCA, at which point the Company will be internally managed. The Company expects this to happen imminently;

- The Company is actively considering a number of proposals which may lead to investments during the first half of 2020; and

- In addition, prior its appointment the new Board indicated it would pay a special dividend of 4.25p per share if appointed. This dividend was paid on 15 January 2020.

 

Further information on the Company's new internal management arrangements, investment approach and its pipeline of opportunities will be provided in the Company's full results announcement in March 2020. 

 

Net Asset Value estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third-party fund manager valuations. The Board currently estimates that the year-end net asset value ("NAV"), after deducting £3.4 million (4.25p per share) for the special dividend paid on 15 January 2020, will be in the region of £52.6 million (65.1p per share). Prior to accounting for the dividend, NAV at 31 December 2019 would be in the region of £56.0 million (69.4p per share); this compares to £58.7 million (72.7p per share) at 30 September 2019, £59.1 million (73.3p per share) at 30 June 2019 and £60.3 million (74.7p per share) at 31 December 2018.

 

This estimate reflects information currently available to the Board on the performance and prospects of individual investments in the Company's portfolio and is subject to further evaluation as well as completion of the annual audit.

 

The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines. 

 

The £3.1 million reduction in NAV, before accounting for the special dividend, compared to the half year comprises the following principal elements:

·; A reduction in the investment portfolio of £(0.6), being unrealised foreign exchange losses arising from the weakening of the US Dollar compared to sterling in the period 30 June 2019 to 31 December 2019;

·; Realised foreign currency gains of £0.6 million on the sale of US Dollars principally from the sale of Entuity in August 2019;

·; Excluding the effect of foreign exchange rate changes, the portfolio showed a net loss of £(0.6) million in the second half of 2019:

o an increase of £2.5 million in the net proceeds on the sale of Entuity in August, with a corresponding increase in the NAV, over and above the net proceeds anticipated in the 30 June 2019 valuation;

o an increase of £1.2 million in the market valuation of quoted stocks, principally Solaredge and IDE Group;

o other portfolio gains of £0.6 million;

o a reduction of £(2.8) million in the value of YesTo. This reduction reflects a deterioration in trading during 2019, the requirement to make changes in the company's management and operating structure and the need to provide additional working capital finance;

o a reduction of £(2.1) million in the value of Medhost reflecting a corresponding reduction in value by Primus, the lead investment manager, in its latest available fund report; and

·; Other movements were a reduction of £2.5 million being:

o Overheads of £1.1 million in the second half of 2019. Full year 2019 overheads were £1.8 million (£1.5 million in 2018) and increased over the prior year primarily due to the cessation in August 2019 of a credit of £0.3 million per year, as required by GAAP, arising from amortising shares received by the Company from GHAM at the inception of the management contract;

o One-off exceptional costs of £1.4 million, in relation to the resetting of the Company's investment strategy and its return to internal management;

 

 

The one-off exceptional costs arise from the review of the investment management arrangements which culminated in the General Meeting on 28th November 2019. They include:

·; the costs of the former independent directors in running a tender process for the Company's investment management arrangements (as referenced in the Company's announcement on 26 July 2019);

·; the costs of the circular and other shareholder communications, both for and against the proposals, leading up to the general meeting;

·; other advisory costs incurred by the parties in the course of seeking to resolve the differences of view as to the investment management arrangements for the Company; and

·; provision for amounts payable to GHAM for the period January 2020 to May 2020 in accordance with the termination arrangements agreed between the Company and GHAM.

 

Further information on the performance of the portfolio, underlying investment valuations and changes during the current year will be included in the Company's audited results for the year ended 31 December 2019, which it expects to announce in March 2020.

Group cash balances at 31 December 2019 were £26.7 million.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact: 

 

LMS Capital PLC

Nick Friedlos, Managing Director 020 7935 3555 or 0207 938 2440

 

Shore Capital

Robert Finlay 0207 405 4850

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFLILTIIVII
Date   Source Headline
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:36 pmRNSPrice Monitoring Extension
2nd Feb 20217:00 amRNSNAV and Portfolio Update
7th Jan 20211:59 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.